The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation

Becky Pennington,Emily Ruth Marriott,Peter Lichtlen,Ayesha Akbar,Anthony J. Hatswell

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation

2018

Becky Pennington
Emily Ruth Marriott
Peter Lichtlen
Ayesha Akbar
Anthony J. Hatswell

Objective The objective of this study was to evaluate the cost effectiveness of lubiprostone, prucalopride, placebo and immediate referral to secondary care in chronic idiopathic constipation (CIC) in an economic model that was used by the UK National Institute for Health and Care Excellence (NICE) in developing guidance.

Keywords:

Placebo
Lubiprostone
Physical therapy
Excellence
Prucalopride
Nice
Chronic idiopathic constipation
Referral
Medicine
Intensive care medicine
Health care
Quality of life
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations